Yu et al. [24] showed that the activation of the PKCε-ALDH2 regulatory axis may be a therapeutic target for treating obesity and type 2 diabetes in mice. This evidence concerns the gene ALDH2 and obesity due to melanocortin 4 receptor deficiency.